2-cyano-1-(2-((3-fluorobenzyl)thio)ethyl)-3-methylguanidine

ID: ALA5182787

Chembl Id: CHEMBL5182787

PubChem CID: 168280479

Max Phase: Preclinical

Molecular Formula: C12H15FN4S

Molecular Weight: 266.35

Associated Items:

Names and Identifiers

Canonical SMILES:  CN/C(=N\C#N)NCCSCc1cccc(F)c1

Standard InChI:  InChI=1S/C12H15FN4S/c1-15-12(17-9-14)16-5-6-18-8-10-3-2-4-11(13)7-10/h2-4,7H,5-6,8H2,1H3,(H2,15,16,17)

Standard InChI Key:  XORPQDUWRNXLKT-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5182787

    ---

Associated Targets(Human)

SLC47A1 Tchem Multidrug and toxin extrusion protein 1 (147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
hmrM Multidrug resistance protein HmrM (40 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 266.35Molecular Weight (Monoisotopic): 266.1001AlogP: 1.70#Rotatable Bonds: 5
Polar Surface Area: 60.21Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.08CX LogD: 2.08
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.37Np Likeness Score: -2.14

References

1. Shinya S, Kawai K, Kobayashi N, Karuo Y, Tarui A, Sato K, Otsuka M, Omote M..  (2022)  Fluorophenylalkyl-substituted cyanoguanidine derivatives as bacteria-selective MATE transporter inhibitors for the treatment of antibiotic-resistant infections.,  74  [PMID:36215813] [10.1016/j.bmc.2022.117042]

Source